Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier Régional Metz-Thionville
About this trial
This is a prospective, observational, monocentric, phase II (exploratory) cohort study aiming to describe the evolutionary profile of the initial volume of glucose distribution (IDVG) during the first four days of management of severely burned patient.
Eligibility criteria
Qualifiers
Patients over 18 years of age
Patients hospitalized with burns of at least 30% of body surface area
By a thermal mechanism
At the CHR Metz-Thionville burn center
Disqualifiers
Diabetic patients on insulin
Patient with a CONTRAINDICATION to GLUCOSE 30% PROAMP, solution for injection
Patients with pre-hospital cardiac arrest
extra corporeal circulation patient: Extra Corporeal Membranous Oxygenation (ECMO) or Extra Corporeal Life Support (ECLS) or CRRT (Continuous Renal Replacement Therapy)
Trial design
Treatments tested in this trial
- Glucose 30% Intravenous Solution
Treatment groups
15 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov